WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award

WuXi PharmaTech (NYSE: WX) CEO Honored with Ernst & Young Entrepreneur Of The Year China 2007 Award

October 29, 2007

    SHANGHAI, China, Oct. 29 /Xinhua-PRNewswire/ -- WuXi
PharmaTech (NYSE: WX), China's premier provider of
pharmaceutical R&D outsourcing services announced today
that Dr. Ge Li, the company's Chairman and Chief Executive
Officer received the Ernst & Young Entrepreneur Of The
Year (EOY) China 2007 Award.  This prestigious award was
presented to Dr. Li and 10 other elite entrepreneurs on
October 26 in the China World Hotel, Beijing, China.
    (Logo: http://www.xprn.com/xprn/sa/200708281726-min.jpg
)
    The Ernst & Young Entrepreneur of the Year Awards
China program was founded by Ernst & Young to champion
entrepreneurs, whose ideas, vision and energy have prompted
profound change in the Chinese economy and who have shown
entrepreneurial spirit.  This year's recipients include
Charles Zhang, Chairman and CEO of Sohu.com Inc. -- the
fourth most popular website in China and 22nd most popular
website in the world, and Zhengrong Shi, Chairman and CEO
of Suntech Power Holdings Co. Ltd. -- the leading solar
energy company in China and the fourth largest solar energy
equipment maker in the world.
    The judges of the selection panel are drawn from those
at the forefront of the business and academic communities. 
According to the panel, winners are selected based on the
following criteria: entrepreneurial spirit, corporate
financial performance, strategic direction, national or
global impact, innovation, and personal integrity and
influence.
    Dr. Li is honored as the only winner to represent the
pharmaceutical sector in China.  "He has influenced
the way big pharmaceutical companies think about China, and
China's respect for intellectual property," according
to Ernst & Young.
    "I'm deeply honored to be listed among China's
finest entrepreneurs," commented Dr. Ge Li, Chairman
and Chief Executive Officer of WuXi PharmaTech.  "I'm
very proud to see WuXi PharmaTech's success recognized by
Ernst & Young.  Our business has grown in leaps and
bounds from an ordinary start-up to an NYSE listed company,
but our entrepreneurial spirit has never diminished.  This
award will spur us on to pursue the highest levels of
integrity, quality, and professionalism in providing a full
range of sophisticated drug R&D services to our
customers.
    "Winners at the Ernst & Young Entrepreneur of
the Year Award China 2007 will join the China EOY Academy,
comprising current and past winners from China.  All award
winners will also be inducted into the World EOY Academy, a
global forum.

    About The Ernst & Young Entrepreneur Of The Year
(EOY) Awards
    The Ernst & Young Entrepreneur Of The Year (EOY)
Awards program is the world's most prestigious business
accolade for entrepreneurs.  Recognized globally, the
awards honor the most outstanding entrepreneurs who inspire
others with their vision, leadership and achievement. 
Created in the United States in 1986, the Ernst & Young
Entrepreneur of the Year Awards program has now expanded to
more than 125 cities in 40 countries, with awards presented
to over 900 of the world's most successful and innovative
entrepreneurs.

    About Ernst & Young
    Ernst & Young is one of the world's largest
professional services firms, it provides clients with
assistance in all kind of business issues including audit,
tax, corporate finance, transactions, online security, and
enterprise risk management.  For more information please
visit http://www.ey.com .

    About WuXi PharmaTech
    Founded in 2000, Shanghai-based WuXi PharmaTech is the
leading China-based pharmaceutical and biotechnology
R&D outsourcing company. As a research- driven and
customer-focused company, WuXi PharmaTech provides
pharmaceutical and biotechnology companies a broad and
integrated portfolio of laboratory and research
manufacturing services throughout the drug discovery and
development process. WuXi PharmaTech's services are
designed to assist its global partners in shortening the
cycle and lowering the cost of drug discovery and
development by providing cost-effective and efficient
outsourcing solutions that save its customers both time and
money. Its operations are grouped into two segments:
laboratory services, consisting of discovery chemistry,
service biology, analytical, toxicology, pharmaceutical
development and process development services, and
manufacturing, focusing on manufacturing of advanced
intermediates and active pharmaceutical ingredients for
R&D use. In 2006, WuXi PharmaTech provided services to
70 pharmaceutical and biotechnology customers, including
nine of the top ten pharmaceutical companies in the world,
as measured by 2006 total revenues. For more information,
please visit: http://www.wuxipharmatech.com .


    For more information, please contact:

     Sherry Shao
     Tel:   [phone]
     Email: [e-mail]